Cargando...
Targeting ATR/CHK1 pathway in acute myeloid leukemia to overcome chemoresistance
Resistance of acute myeloid leukemia to current therapies leads to frequent relapses. Identification of molecular mechanisms involved in chemoresistance constitutes a key challenge to define new therapeutic concepts. Here, we show that the ATR/CHK1 pathway, essential in maintaining genomic stability...
Gardado en:
| Publicado en: | Mol Cell Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5644474/ https://ncbi.nlm.nih.gov/pubmed/29057300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1289293 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|